Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Arrowhead Pharmaceuticals (ARWR) Receivables - Other (2019 - 2025)

Arrowhead Pharmaceuticals' Receivables - Other history spans 9 years, with the latest figure at $9.8 million for Q4 2025.

  • For Q4 2025, Receivables - Other changed N/A year-over-year to $9.8 million; the TTM value through Dec 2025 reached $9.8 million, changed N/A, while the annual FY2022 figure was $4.8 million, 52.0% down from the prior year.
  • Receivables - Other reached $9.8 million in Q4 2025 per ARWR's latest filing, down from $25.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $25.0 million in Q4 2022 to a low of $100000.0 in Q4 2021.
  • Average Receivables - Other over 3 years is $7.2 million, with a median of $4.8 million recorded in 2022.
  • Peak YoY movement for Receivables - Other: tumbled 98.78% in 2021, then skyrocketed 24900.0% in 2022.
  • A 3-year view of Receivables - Other shows it stood at $100000.0 in 2021, then surged by 24900.0% to $25.0 million in 2022, then plummeted by 60.69% to $9.8 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Receivables - Other are $9.8 million (Q4 2025), $25.0 million (Q4 2022), and $4.8 million (Q3 2022).